{"id":5464,"date":"2017-01-02T08:23:13","date_gmt":"2017-01-02T13:23:13","guid":{"rendered":"https:\/\/medicarereport.org\/?p=5464"},"modified":"2017-01-02T08:23:13","modified_gmt":"2017-01-02T13:23:13","slug":"new-drugs-approvals-slowed-down-in-2016","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=5464","title":{"rendered":"New Drugs Approvals Slowed Down in 2016"},"content":{"rendered":"<p><span style=\"color: #000000; font-family: Calibri;\">The Food and Drug Administration cleared only twenty-two new medicines for sale in 2016 compared to forty-five in 2015.<\/span><span style=\"color: #000000; font-family: Calibri;\">\u00a0 <\/span><span style=\"color: #000000; font-family: Calibri;\"><a href=\"http:\/\/www.reuters.com\/article\/us-pharmaceuticals-approvals-idUSKBN14M08R\" target=\"_blank\">Read article here\u2026<\/a><\/span><\/p>\n<pre style=\"border: 1px solid #eaeaea; font-variant-ligatures: normal; font-variant-caps: normal; font-variant-numeric: inherit; font-stretch: inherit; line-height: 1.4; font-family: 'Courier 10 Pitch', Courier, monospace; font-size: 14px; font-style: normal; font-weight: normal; margin: 0px 0px 20px; outline: 0px; padding: 20px; vertical-align: baseline; background-color: #ffffff; overflow: auto; white-space: pre-wrap; color: #444444; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px;\"><strong>Notice<\/strong>: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>The Food and Drug Administration cleared only twenty-two new medicines for sale in 2016 compared to forty-five in 2015.\u00a0 Read<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[15],"tags":[],"class_list":["post-5464","post","type-post","status-publish","format-standard","hentry","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5464","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5464"}],"version-history":[{"count":1,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5464\/revisions"}],"predecessor-version":[{"id":5465,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/5464\/revisions\/5465"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5464"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=5464"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=5464"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}